Dreaming of long lashes? Some eyelash serums, including a popular one by Babe Lash,
Learn the truth behind the Babe Lash lawsuit and the FDA’s stance on isopropyl cloprostenate (ICP) in eyelash growth products. Prioritize safety and protect your rights by understanding the potential dangers and regulations.
Dreaming of long lashes? Some eyelash serums, including a popular one by Babe Lash, have caused serious side effects, leading to lawsuits from unhappy customers.
Babe Lash, made by Elixir Cosmetics, promises longer and fuller lashes. Founded in 1983, Elixir Cosmetics specializes in collagen research and hair care products. The Babe Lash line has gained popularity through online platforms and social media but is now facing legal troubles due to its eyelash and brow-enhancing serums.
On May 5, 2024, Melanie Wohl and Dalit Cohen from New York filed a class action lawsuit against Elixir Cosmetics. They bought Babe Lash serum from Walmart, believing it was safe. The product’s packaging and ads did not mention that it contained isopropyl cloprostenate (ICP), a drug ingredient that can cause serious side effects. The plaintiffs claim they would not have bought the serum if they had known the truth.
Isopropyl cloprostenate (ICP) is a synthetic prostaglandin analog used in eyelash growth serums to lengthen and thicken eyelashes. However, ICP can cause side effects like eye irritation, permanent dry eyes, iris discoloration, dark under-eye circles, spotting of the iris, and loss of eyelashes. Elixir Cosmetics advertises Babe Lash as a cosmetic product that can increase eyelash length and thickness without warning consumers about the serious side effects of ICP.
The FDA has warned cosmetics manufacturers about the risks of ICP, stating that products containing ICP need approval. Despite these warnings, Elixir continues to sell Babe Lash as a cosmetic product without FDA approval. Many customers have complained about side effects, but Elixir has dismissed these issues.
In a related case, Danielle Skarpnes filed a class action Babe Lash lawsuit against Elixir on October 12, 2023, for not warning about the risks linked to ICP. Following this claim, Babe Lash agreed to a $2.3 million settlement. The settlement covers anyone who bought Babe Lash products between June 1, 2019, and January 19, 2024. To receive compensation, claims must be submitted by April 19, 2024.
In conclusion,
In conclusion, Eyelash growth products can offer cosmetic benefits, but it’s crucial to be aware of the potential risks, especially when using products with unapproved ingredients like isopropyl cloprostenate. Always prioritize safety by researching products, consulting healthcare professionals, and knowing your legal rights. while long lashes are desirable, safety is essential. If you’ve experienced adverse effects from lash serums like Babe Lash, contact a lawyer.
© 2024 Crivva - Business Promotion. All rights reserved.